Xenotransplantation: Where are we today?

Valderrabano F. , Jones E.H. , Mallick N.P. Report on management of renal failure in Europe, XXIV, 1993. Nephrology Dial Transplant 1995; 10(suppl 5): 1–25

Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int 1993; 40: S23–7

Aranzabal J. , Perdigo L. , Mijares J. , Villar F. Renal transplantation costs: an economic analysis and comparison with dialysis costs. Transplant Proc 1991; 23: 2574

UK Transplant. United Kingdom Preliminary Data. Bristol: UK Transplant, 2002

Duncan B.W. Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg 2002; 73: 1670–7

Devine S.M. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem 2002; (suppl 38): 73–9

Reemtsma K. Renal heterotransplantation. Adv Surg 1966; 2: 285–93

Collins B.H. Porcine islets as an alternative to human islets for transplantation. J Invest Med 2001; 49: 576–9

Larsson L.C. , Widner H. Neural tissue xenografting. Scand J Immunol 2000; 52: 249–56

Frankish H. Pig organ transplantation brought one step closer. Lancet 2002; 359: 137

Weiss R.A. , Magre S. , Takeuchi Y. Infection hazards of xenotransplantation. J Infect 2000; 40: 21–5

Evans D.B. , Cornette J.C. , Sawyer T.K. , Staples D.J. , de Vaux A.E. , Sharma S.K. Substrate specificity and inhibitor structure-activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors. Biotechnol Appl Biochem 1990; 12: 161–75

Soin B. , Smith K.G. , Zaidi A. , Cozzi E. , Bradley J.R. , Ostlie D.J. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001; 60: 1592–7

Cooper D.K. , Gollackner B. , Sachs D.H. Will the pig solve the transplantation backlog? Annu Rev Med 2002; 53: 133–47

Sandrin M.S. , Vaughan H.A. , Dabkowski P.L. , McKenzie I.F. Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391–5

Galili U. , Mandrell R.E. , Hamadeh R.M. , Shohet S.B. , Griffiss J.M. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730–7

Artrip J.H. , Kwiatkowski P. , Michler R.E. Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)-galactosyltransferase and reduced by alpha(1,2)-fucosyltransferase. [erratum appears in J Biol Chem 1999; 274: 15292.] J Biol Chem 1999; 274: 10717–22

Azimzadeh A. , Meyer C. , Watier H. Removal of primate xenoreactive natural antibodies by extracorporeal perfusion of pig kidneys and livers. Transpl Immunol 1998; 6: 13–22

Tanemura M. , Yin D. , DiSesa V.J. , Galili U. Preventing anti-Gal response in xenograft recipients by an alpha-Gal toxin. Transplant Proc 2001; 33: 699–700

Leventhal J.R. , Dalmasso A.P. , Cromwell J.W. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857–65

Dalmasso A.P. , Platt J.L. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993; 56: 1171–6

Hecker J.M. , Lorenz R. , Appiah R. C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation 2002; 73: 688–94

Huang J. , Gou D. , Zhen C. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. FEMS Immunol Med Microbiol 2001; 31: 203–9

Bach F.H. , Robson S.C. , Winkler H. Barriers to xenotransplantation. Nature Med 1995; 1: 869–73

Cozzi E. , Bhatti F. , Schmoeckel M. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15–21

Vangerow B. , Hecker J.M. , Lorenz R. C1-inhibitor for treatment of acute vascular xenograft rejection in cynomolgus recipients of h-DAF transgenic porcine kidneys. Xenotransplantation 2001; 8: 266–72

Bach F.H. , Robson S.C. , Wrighton C.J. , Stuhlmeier K. , Ferran C. , Winkler H. Genetic engineering of endothelial cells to ameliorate xenograft rejection. Clin Transplant 1996; 10(1 pt 2): 124–7

Riesbeck K. , Chen D. , Kemball-Cook G. Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis. Circulation 1998; 98: 2744–52

Miyagawa S. , Murakami H. , Takahagi Y. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001; 276: 39310–19

Sharma A. , Okabe J. , Birch P. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190–5

LaTemple D.C. , Galili U. Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation 1998; 5: 191–6

Lai L. , Kolber-Simonds D. , Park K.W. Production of alpha-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089–92

Shimizu A. , Meehan S.M. , Kozlowski T. Acute humoral xenograft rejection: destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000; 80: 815–30

Holmes B.J. , Richards A. , McLaughlin M. Antibody responses in early graft rejection in pig-to-primate renal xenotransplantation. Transplant Proc 2001; 33: 717–18

Robson S.C. , Cooper D.K. , d'Apice A.J. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166–76

Taniguchi S. , Neethling F.A. , Korchagina E.Y. et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 1996; 62: 1379–84

Robson S.C. , Young V.K. , Cook N.S. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 1996; 61: 862–8

Teranishi K. , Gollackner B. , Buhler I. Depletion of anti-gal antibodies in baboons by intravenous therapy with bovine serum albumin conjugated to gal oligosaccharides. Transplantation 2002; 73: 129–39

Squinto S.P. Genetically modified animal organs for human transplantation. World J Surg 1997; 21: 939–42

Ildstad S.T. , Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168–70

Abe M. , Qi J. , Sykes M. , Yang Y.G. Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier. Blood 2002; 99: 3823–9

Sablinski T. , Gianello P.R. , Bailin M. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121: 381–91

Yamada K. , Shimizu A. , Utsugi R. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients. J Immunol 2000; 164: 3079–86

Specke V. , Rubant S. , Denner J. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 2001; 285: 177–80

Paradis K. , Langford G. , Long Z. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236–41